We report a rare case of pla sma cytom a ofthe nasal cavity in a 60-year-old man. The patient had a history of a steadily grow ing and palp abl e mass in the open ing ofthe left nostril. The tum or was fo und to be localized, and it was identified as an extramedulla ry plasmacytoma. The patient underwent therapy with 55 Gy of radiation. Six month sfo llow ing the cessation ofradi oth erapy, the size of the tumor had not changed. The ma ss was then comp lete ly excised und er microscopi c vision. Hist opathologic exam ination ident ified the growth as a plasmacytoma with monotyp ic light-cha in exp ression. To op timize the management of patients with an extramedullary plasmacytoma ofthe head and neck, interdisc ip linary management is mandatory.
Introduction
Depending on their site of development and clinical features, malignant tumor s of monoclonal antibody-producing plasm a cells are classified as either multiple myelomas, solitary plasmacytomas, or extramedullary pl asmacytomas ,' Extramedullary pla sm acytomas account for 4% of all nonepithelial tumors of the nasal cavity ,paranasal sinuses, and nasopharynx, and they are found in 0.4 % of all head and neck malign ancie s.' The se tumors have been reported to occur simultaneously at different sites in the head and neck in 10 to 20% of patients.2-4 Approximatel y 80% of extramedullary plasmac ytomas are localized in the submuco sa of the upper respiratory tract, and they usually occur in patients between the ages of 50 and 60 years." From The postdiagno sis clinic al cour se is unpr edict able and varies among individuals.' Between 10 and 32% of all patients develop multiple myelom a following diagn osis, which dram atically redu ces the mean survival time from 8.3 years to 20 month s.P'" Recurrent extramedull ary plasm acytom as are often succes sfully treat ed only with surgery.'
In this article, we describe a case of extramedullary plasmacytom a in the nasal cavity that was diagnosed by chance and treated initially with radiation therapy and later with surgery.
Case report
A 60-year-old man was referred to our clin ic after he had palpated a nasal mass at the piriform aper ture on the left side (figure 1). His breathing was only slightly impai red, and he experienced no spontaneous bleeding. Endoscopic examination confirmed the presence of the dark-red submuco sal mass at the piriform aperture on the left side of the floor of the nasal cavity. No cervical lymph nodes were palpable or det ected by ultrasound.
Histop atholog ic examination of a biopsy specimen iden tified a malignant lymphoma. Further analysis revealed that the mass was an extramedull ary pla smacytom a with expres sion of A light chains ; no heavy-chain expre ssion was detected (figure 2). The tumor cells were positive for CD 138 and syndecan and negative for CD20 (a pan-B-cell marker). Intermin gled cell s were positive for CD3 (a pan-T-cell marker ). A bone marrow biop sy, chest x-ray, total-body skeletal survey, and 99m technetium scintigraphy did not detect any systemic lesion. Tests for Bence Jones protein in the urine and for serum myelom a prote in were negat ive. Computed tomography (CT) of the head and neck demon strated that the paran asal sinuses and adjacent bone s were not affected. These findings confi rmed the diagno sis of a stage IA extramedullary plasmac ytoma (Durie and Salmon classification).
The tumor was irradiated with 55 Gy (usually at 2 Gy/ day), but it did not shrink ( figure 3 ). Six month s following follow-up, there was no sign of recurrence .
Discussion
Plasma cells are mature imm unocompetent ce lls that are der ived from B lymph ocytes, and they pro vide specific noncellul ar immunity wit hin the immune system. They evade blood vesse ls after a short time of circulation and produce specific antibodies agai nst antigens in different tiss ues . Larger pop ulations are seen in the mucosa of the nasal and para nasa l sinuses. Plasmacytomas arise fro m a neoplas tic proliferation of these antibo dy-producing plasm a cells. The three types of plasmacy tomas-multiple myelomas, solitary plasmacytomas, and extrame dulla ry plas macytomas-are further classified as either localized (stage I), localized including local lymph nodes (stage II), or genera lized (stage III), according to their clinical manifesta tion. ' Th e firs t case of extramedullary plasmacytoma was repor ted in 1905. 8 Approximate ly 80% of cases occur in the upper resp iratory tract, and 10 to 20 % manifest as multi ple lesions.i? T he most freque ntly affected areas are the nasa l cavity and para nasa l sinuses , followed by the nasopharynx, tonsi ls, and pharynx."A sys temat ic metho d Th e treatm ent of localized ex tra medullary plas macytoma is still a matter of so me debate; some clin icians favor radiotherapy. v' " others prefer surgical manageme nt,' an d so me advocate a co mb ination of both.' ? As was the case in our patient , rad ioth erapy does not always redu ce the size of the tum or , per haps becau se of an abunda nt deposition of amyloid within the mass." Fortu nately , the tumor in our patient was resectable, but this is not always the case. In any eve nt, regul ar examinations by an otolaryngologist should be perform ed on every patient with an ex tra me dullary plas macytoma of the head and neck as long as the pa tient lives.
Chemo therapy is advisable on ly for patient s who have a genera lized ex tra medullary plasm acytom a. Th e 5-year surv iva l ra te amo ng these patient s has been report ed to range bet ween 53 and 75 %.3 Because each indivi dual clinica l course is unp redi ct able and because the developme nt of multiple myelom as has been observed in 10 to 32 % of patient s 28 to 36 years later , lifet ime fo llow-up is aga in ma nda tory .v' <! ' A l O-year survival rate of about 50 % ca n be ex pec ted. 12 Th e optima l therap y for patient s with an ex tra me dullary plasm acytoma of the head and neck ca n be ac hieved only by an interdisciplin ary app roac h. Exten sion "OE98-8" also available for tubular su pport For more information Circle 116 on Reader Service C ard
